文献速递脑血管病

美国卒中后tPA与取栓术使用的十年年龄、性别和种族差异趋势

Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States.
PubMed 文献 · Stroke · 2021-06-03

结果显示各年龄组和种族的使用率均上升,年龄与性别相关治疗差距缩小,但黑人患者使用率仍低于白人患者,种族差距虽在缩小但持续存在。

要点

  • 各年龄组IV tPA和MT使用率十年间均上升,高龄组上升更快。
  • 黑人患者IV tPA和MT使用率多数年龄组低于白人患者。
  • 种族与性别相关治疗差距随时间缩小,但黑人患者差距仍存在。

核心结论

  • 十年间IV tPA和MT使用中的年龄与性别相关治疗差距缩小,但黑人相较白人患者的种族差异持续存在,不过该差距也在缩小。

研究设计与样本

  • 回顾性分析2008至2017年美国全国住院患者样本中成人急性缺血性卒中住院(加权n=4 442 657),用ICD编码识别,采用Joinpoint及多变量校正logistic回归评估趋势。

主要发现

  • 全期32.4%的住院为≥80岁患者,其中64.7%为女性。
  • IV tPA使用比例最高为18至39岁组(12.3%),最低为≥90岁组(7.9%)。
  • 所有年龄组两种治疗使用率均上升,≥90岁组上升快于18至39岁组(MT:每增加一年比值比1.25,95%CI 1.20–1.35,交互P<0.001)。
  • 多数年龄组黑人患者IV tPA和MT使用率低于白人患者。
  • 2015年后除60至79岁和≥80岁黑人患者外,各人群亚组IV tPA使用率均>10%。

关键数值与推荐

  • 黑人相较白人IV tPA治疗差距随时间缩小(比值比1.02,95%CI 1.01–1.03,交互P<0.01)。
  • 黑人相较白人MT治疗差距随时间缩小(比值比1.08,95%CI 1.05–1.12,交互P<0.01)。
  • IV tPA使用存在性别差异,但该差距随时间缩小。

临床怎么用

  • 监测不同年龄、性别和种族亚组的再灌注治疗使用,识别并缩小持续存在的黑人患者治疗差距。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: IV tPA (intravenous thrombolysis with alteplase) and mechanical thrombectomy (MT) utilization increased in acute ischemic stroke hospitalizations in the United States over the last decade. It is uncertain whether this increase occurred equally across all age, sex, and racial groups. METHODS: Adult acute ischemic stroke hospitalizations (weighted n=4 442 657) contained in the 2008 to 2017 National Inpatient Sample were identified using International Classification of Diseases codes. Proportions of hospitalizations with IV tPA and MT were computed according to age, sex, and race. Joinpoint and multivariable-adjusted logistic regression models were used to evaluate trends over time. RESULTS: Across this period, 32.4% of all hospitalizations were in patients ≥80 years, and 64.7% of these were women. IV tPA and MT use differed by age with highest proportion of utilization of both treatments in patients aged 18 to 39 years (IV tPA, 12.3%) and lowest percentage in patients aged ≥90 years (IV tPA, 7.9%). Utilization of both procedures increased over time in all age groups, but the pace of increase was faster in patients ≥90 years compared with patients aged 18 to 39 years (MT: odds ratio, 1.25 [95% CI, 1.20–1.35] per unit increase in year, P interaction <0.001). Frequency of utilization of IV tPA and MT was lower in Black patients compared with White patients in most age groups. Usage of both procedures increased over time in all races and after 2015, IV tPA utilization was >10% in all demographic subgroups except in Black patients 60 to 79 years and Black patients ≥80 years. Analysis of race-by-time interaction revealed the Black-vs-White treatment gaps for IV tPA (odds ratio, 1.02 [95% CI, 1.01–1.03]) and MT (odds ratio, 1.08 [95% CI,1.05–1.12]) declined over time (both P interaction <0.01). Sex-related differences in IV tPA use were noted, but this gap also declined over time. CONCLUSIONS: Age- and sex-related treatment gaps in IV tPA and MT reduced over the last decade. Racial disparity in IV tPA and MT utilization persists with particularly lower frequency of usage of both acute stroke treatments in Black patients compared with White patients, but race-associated treatment gaps also declined over time.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Otite FO, Saini V, Sur NB, et al. Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States. Stroke. 2021. PMID: 34078107. doi:10.1161/STROKEAHA.120.032132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。